Kruse Bo - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on May 31, 2024, Kruse Bo's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Officer (EVP, CFO, SECRY & TREAS.), and currently has 242,248 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other YMAB insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Kruse Bo - Insider Non-Derivative Transactions of YMAB Common Stock
Kruse Bo - Insider Non-Derivative Transactions at YMAB
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 1, 2024 | Sell -- (Common Stock) | 31371 | 12.07 | 210877 |
| Jun 1, 2024 | M -- (Common Stock) | 31371 | 2 | 242248 |
| May 31, 2024 | Sell -- (Common Stock) | 28629 | 12.03 | 210877 |
| May 31, 2024 | M -- (Common Stock) | 28629 | 2 | 239506 |
| Jan 19, 2024 | Acquisition -- (Common Stock) | 18100 | 0 | 210877 |
| Jan 18, 2023 | Acquisition -- (Common Stock) | 11700 | 0 | 192777 |